Nicotine Promotes Cholangiocarcinoma Growth in Xenograft Mice

American Journal of Pathology

Volumn 187, Issue 5, 2017, Pages 1093-1105

  Martínez, Allyson K ^a   Jensen, Kendal ^a   Hall, Chad ^a   O'Brien, April ^a   Ehrlich, Laurent ^a   White, Tori ^a   Meng, Fanyin ^a,b,c   Zhou, Tianhao ^a   Greene, John ^c   Bernuzzi, Francesca ^d,e   Invernizzi, Pietro ^d,e   Dostal, David E ^a,b   Lairmore, Terry ^a   Alpini, Gianfranco ^a,b,c   Glaser, Shannon S ^a,b,c  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

^e HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 CHLORO N (3 QUINUCLIDINYL)BENZAMIDE; BUNGAROTOXIN RECEPTOR; CALVASCULIN; CYTOKERATIN 19; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; KI 67 ANTIGEN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINE; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINIC AGENT;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT CARCINOMA; CELL PROLIFERATION; CHOLANGIOCARCINOMA CELL LINE; CHOLANGIOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; IN VITRO STUDY; MALE; MIDDLE AGED; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; BILE DUCT TUMOR; CANCER TRANSPLANTATION; DRUG EFFECTS; FIBROSIS; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; XENOGRAFT;

AGED; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; BILE DUCT NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLANGIOCARCINOMA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FIBROSIS; HETEROGRAFTS; HUMANS; KERATIN-19; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; NICOTINE; NICOTINIC AGONISTS; S100 CALCIUM-BINDING PROTEIN A4;

EID: 85019045971     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2017.01.011     Document Type: Article

References (52)

1. 1 World Health Organization, Research for International Tobacco Control. WHO Report on the Global Tobacco Epidemic, 2011: Warning about the Dangers of Tobacco. 2011, World Health Organization, Geneva, Switzerland.
2. 2 Rivenson, A., Hoffmann, D., Prokopczyk, B., Amin, S., Hecht, S.S., Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res 48 (1988), 6912–6917.
3. 3 Novello, A.C., Surgeon General's report on the health benefits of smoking cessation. Public Health Rep 105 (1990), 545–548.
4. 4 Vial, M., Grande, L., Pera, M., Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Recent Results Cancer Res 182 (2010), 1–17.
5. 5 Grainge, M.J., West, J., Solaymani-Dodaran, M., Aithal, G.P., Card, T.R., The antecedents of biliary cancer: a primary care case-control study in the United Kingdom. Br J Cancer 100 (2009), 178–180.
6. 6 Shaib, Y.H., El-Serag, H.B., Davila, J.A., Morgan, R., McGlynn, K.A., Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 128 (2005), 620–626.
7. 7 Tyson, G.L., El-Serag, H.B., Risk factors for cholangiocarcinoma. Hepatology 54 (2011), 173–184.
8. 8 Welzel, T.M., Graubard, B.I., El-Serag, H.B., Shaib, Y.H., Hsing, A.W., Davila, J.A., McGlynn, K.A., Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol 5 (2007), 1221–1228.
9. 9 Zhou, Y.M., Yin, Z.F., Yang, J.M., Li, B., Shao, W.Y., Xu, F., Wang, Y.L., Li, D.Q., Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China. World J Gastroenterol 14 (2008), 632–635.
10. 10 Cardenas, L., Tremblay, L.K., Naranjo, C.A., Herrmann, N., Zack, M., Busto, U.E., Brain reward system activity in major depression and comorbid nicotine dependence. J Pharmacol Exp Ther 302 (2002), 1265–1271.
11. 11 Cahill, K., Stead, L.F., Lancaster, T., Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev, 2011, CD006103.
12. 12 Hukkanen, J., Jacob, P. 3rd, Benowitz, N.L., Metabolism and disposition kinetics of nicotine. Pharmacol Rev 57 (2005), 79–115.
13. 13 Benowitz, N.L., Drug therapy: pharmacologic aspects of cigarette smoking and nicotine addition. N Engl J Med 319 (1988), 1318–1330.
14. 14 Jensen, K., Afroze, S., Ueno, Y., Rahal, K., Frenzel, A., Sterling, M., Guerrier, M., Nizamutdinov, D., Dostal, D.E., Meng, F., Glaser, S.S., Chronic nicotine exposure stimulates biliary growth and fibrosis in normal rats. Dig Liver Dis 45 (2013), 754–761.
15. 15 Egleton, R.D., Brown, K.C., Dasgupta, P., Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci 29 (2008), 151–158.
16. 16 Schuller, H.M., Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?. Nat Rev Cancer 9 (2009), 195–205.
17. 17 Lazaridis, K.N., Gores, G.J., Cholangiocarcinoma. Gastroenterology 128 (2005), 1655–1667.
18. 18 Marsh Rde, W., Alonzo, M., Bajaj, S., Baker, M., Elton, E., Farrell, T.A., Gore, R.M., Hall, C., Nowak, J., Roy, H., Shaikh, A., Talamonti, M.S., Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part I: diagnosis-clinical staging and pathology. J Surg Oncol 106 (2012), 332–338.
19. 19 Alpini, G., McGill, J.M., LaRusso, N.F., The Pathobiology of Biliary Epithelia. ed 4, 2001, Lippincott Williams & Wilkins, Philadelphia, PA.
20. 20 Sirica, A.E., Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy. Hepatology 41 (2005), 5–15.
21. 21 Knuth, A., Gabbert, H., Dippold, W., Klein, O., Sachsse, W., Bitter-Suermann, D., Prellwitz, W., Meyer zum Buschenfelde, K.H., Biliary adenocarcinoma: characterisation of three new human tumor cell lines. J Hepatol 1 (1985), 579–596.
22. 22 Shimizu, Y., Demetris, A.J., Gollin, S.M., Storto, P.D., Bedford, H.M., Altarac, S., Iwatsuki, S., Herberman, R.B., Whiteside, T.L., Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells. Int J Cancer 52 (1992), 252–260.
23. 23 Wu, T., Leng, J., Han, C., Demetris, A.J., The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells. Mol Cancer Ther 3 (2004), 299–307.
24. 24 Khalil, A.A., Jameson, M.J., Broaddus, W.C., Lin, P.S., Chung, T.D., Nicotine enhances proliferation, migration, and radioresistance of human malignant glioma cells through EGFR activation. Brain Tumor Pathol 30 (2013), 73–83.
25. 25 Rezonzew, G., Chumley, P., Feng, W., Hua, P., Siegal, G.P., Jaimes, E.A., Nicotine exposure and the progression of chronic kidney disease: role of the alpha7-nicotinic acetylcholine receptor. Am J Physiol Renal Physiol 303 (2012), F304–F312.
26. 26 Li, H., Wang, S., Takayama, K., Harada, T., Okamoto, I., Iwama, E., Fujii, A., Ota, K., Hidaka, N., Kawano, Y., Nakanishi, Y., Nicotine induces resistance to erlotinib via cross-talk between alpha 1 nAChR and EGFR in the non-small cell lung cancer xenograft model. Lung Cancer 88 (2015), 1–8.
27. 27 Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983), 55–63.
28. 28 Lopez, M.G., Montiel, C., Herrero, C.J., Garcia-Palomero, E., Mayorgas, I., Hernandez-Guijo, J.M., Villarroya, M., Olivares, R., Gandia, L., McIntosh, J.M., Olivera, B.M., Garcia, A.G., Unmasking the functions of the chromaffin cell alpha7 nicotinic receptor by using short pulses of acetylcholine and selective blockers. Proc Natl Acad Sci U S A 95 (1998), 14184–14189.
29. 29 Han, Y., Onori, P., Meng, F., DeMorrow, S., Venter, J., Francis, H., Franchitto, A., Ray, D., Kennedy, L., Greene, J., Renzi, A., Mancinelli, R., Gaudio, E., Glaser, S., Alpini, G., Prolonged exposure of cholestatic rats to complete dark inhibits biliary hyperplasia and liver fibrosis. Am J Physiol Gastrointest Liver Physiol 307 (2014), G894–G904.
30. 30 Al-Wadei, H.A., Plummer, H.K. 3rd, Schuller, H.M., Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid. Carcinogenesis 30 (2009), 506–511.
31. 31 Wong, H.P., Yu, L., Lam, E.K., Tai, E.K., Wu, W.K., Cho, C.H., Nicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activation. Toxicol Sci 97 (2007), 279–287.
32. 32 Jarzynka, M.J., Guo, P., Bar-Joseph, I., Hu, B., Cheng, S.Y., Estradiol and nicotine exposure enhances A549 bronchioloalveolar carcinoma xenograft growth in mice through the stimulation of angiogenesis. Int J Oncol 28 (2006), 337–344.
33. 33 Lawson, G.M., Hurt, R.D., Dale, L.C., Offord, K.P., Croghan, I.T., Schroeder, D.R., Jiang, N.S., Application of serum nicotine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy. J Clin Pharmacol 38 (1998), 502–509.
34. 34 Navarro, E., Gonzalez-Lafuente, L., Perez-Liebana, I., Buendia, I., Lopez-Bernardo, E., Sanchez-Ramos, C., Prieto, I., Cuadrado, A., Satrustegui, J., Cadenas, S., Monsalve, M., Lopez, M.G., Heme-oxygenase I and PCG-1alpha regulate mitochondrial biogenesis via microglial activation of alpha7 nicotinic acetylcholine receptors using PNU282987. Antioxid Redox Signal, 2016 [Epub ahead of print] doi: 10.1089/ars.2016.6698.
35. 35 Schneider, C.A., Rasband, W.S., Eliceiri, K.W., NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9 (2012), 671–675.
36. 36 Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., Tinevez, J.Y., White, D.J., Hartenstein, V., Eliceiri, K., Tomancak, P., Cardona, A., Fiji: an open-source platform for biological-image analysis. Nat Methods 9 (2012), 676–682.
37. 37 Afroze, S.H., Munshi, M.K., Martinez, A.K., Uddin, M., Gergely, M., Szynkarski, C., Guerrier, M., Nizamutdinov, D., Dostal, D., Glaser, S., Activation of the renin-angiotensin system stimulates biliary hyperplasia during cholestasis induced by extrahepatic bile duct ligation. Am J Physiol Gastrointest Liver Physiol 308 (2015), G691–G701.
38. 38 Menakongka, A., Suthiphongchai, T., Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion. World J Gastroenterol 16 (2010), 713–722.
39. 39 Alpini, G., Kanno, N., Phinizy, J.L., Glaser, S., Francis, H., Taffetani, S., LeSage, G., Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways. Am J Physiol Gastrointest Liver Physiol 286 (2004), G973–G982.
40. 40 Onori, P., Wise, C., Gaudio, E., Franchitto, A., Francis, H., Carpino, G., Lee, V., Lam, I., Miller, T., Dostal, D.E., Glaser, S.S., Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptor. Int J Cancer 127 (2010), 43–54.
41. 41 Meng, F., DeMorrow, S., Venter, J., Frampton, G., Han, Y., Francis, H., Standeford, H., Avila, S., McDaniel, K., McMillin, M., Afroze, S., Guerrier, M., Quezada, M., Ray, D., Kennedy, L., Hargrove, L., Glaser, S., Alpini, G., Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth. Am J Physiol Gastrointest Liver Physiol 306 (2014), G759–G768.
42. 42 Techasen, A., Namwat, N., Loilome, W., Duangkumpha, K., Puapairoj, A., Saya, H., Yongvanit, P., Tumor necrosis factor-alpha modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression. J Hepatobiliary Pancreat Sci 21 (2014), 703–711.
43. 43 Tian, X., Wang, Q., Li, Y., Hu, J., Wu, L., Ding, Q., Zhang, C., The expression of S100A4 protein in human intrahepatic cholangiocarcinoma: clinicopathologic significance and prognostic value. Pathol Oncol Res 21 (2015), 195–201.
44. 44 Ruys, A.T., Groot Koerkamp, B., Wiggers, J.K., Klumpen, H.J., ten Kate, F.J., van Gulik, T.M., Prognostic biomarkers in patients with resected cholangiocarcinoma: a systematic review and meta-analysis. Ann Surg Oncol 21 (2014), 487–500.
45. 45 Dam, M.K., Flensborg-Madsen, T., Eliasen, M., Becker, U., Tolstrup, J.S., Smoking and risk of liver cirrhosis: a population-based cohort study. Scand J Gastroenterol 48 (2013), 585–591.
46. 46 Corpechot, C., Gaouar, F., Chretien, Y., Johanet, C., Chazouilleres, O., Poupon, R., Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosis. J Hepatol 56 (2012), 218–224.
47. 47 Bergquist, A., Glaumann, H., Persson, B., Broome, U., Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 27 (1998), 311–316.
48. 48 Banales, J.M., Masyuk, T.V., Gradilone, S.A., Masyuk, A.I., Medina, J.F., LaRusso, N.F., The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD). Hepatology 49 (2009), 160–174.
49. 49 Fava, G., Marucci, L., Glaser, S., Francis, H., De Morrow, S., Benedetti, A., Alvaro, D., Venter, J., Meininger, C., Patel, T., Taffetani, S., Marzioni, M., Summers, R., Reichenbach, R., Alpini, G., Gamma-Aminobutyric acid inhibits cholangiocarcinoma growth by cyclic AMP-dependent regulation of the protein kinase A/extracellular signal-regulated kinase 1/2 pathway. Cancer Res 65 (2005), 11437–11446.
50. 50 Glaser, S., Lam, I.P., Franchitto, A., Gaudio, E., Onori, P., Chow, B.K., Wise, C., Kopriva, S., Venter, J., White, M., Ueno, Y., Dostal, D., Carpino, G., Mancinelli, R., Butler, W., Chiasson, V., DeMorrow, S., Francis, H., Alpini, G., Knockout of secretin receptor reduces large cholangiocyte hyperplasia in mice with extrahepatic cholestasis induced by bile duct ligation. Hepatology 52 (2010), 204–214.
51. 51 Chen, C.M., Chou, H.C., Huang, L.T., Maternal nicotine exposure induces epithelial-mesenchymal transition in rat offspring lungs. Neonatology 108 (2015), 179–187.
52. 52 Leelawat, K., Keeratichamroen, S., Leelawat, S., Tohtong, R., CD24 induces the invasion of cholangiocarcinoma cells by upregulating CXCR4 and increasing the phosphorylation of ERK1/2. Oncol Lett 6 (2013), 1439–1446.